Toward a Personalized Approach to Parkinson's Cell Therapy
Mov Disord
.
2020 Nov;35(11):2119-2120.
doi: 10.1002/mds.28328.
Authors
Todd M Herrington
1
2
,
Jeffrey Schweitzer
3
4
,
Claire Henchcliffe
5
,
Bob S Carter
3
4
,
Kwang-Soo Kim
6
7
Affiliations
1
Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
2
Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.
3
Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
4
Department of Neurosurgery, Harvard Medical School, Boston, Massachusetts, USA.
5
Department of Neurology, Weill Cornell Medical College, New York, New York, USA.
6
Department of Psychiatry, McLean Hospital, Belmont, Massachusetts, USA.
7
Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
PMID:
33463754
DOI:
10.1002/mds.28328
No abstract available
Publication types
Letter
Comment
MeSH terms
Cell- and Tissue-Based Therapy
Dopamine
Humans
Parkinson Disease* / therapy
Stem Cells
Substances
Dopamine
Grants and funding
K23 NS099380/NS/NINDS NIH HHS/United States